Macrogenics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 23, 2026, 4:05 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
AI summary, unreviewedMacroGenics Reports Interim Phase 1 MGC026 Data: 27% Best ORR in Heavily Pretreated SCCHN, No Discontinuations
8-KAug. 13, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits